Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0085 | 0.9 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |